Argen-X (ARGX) - Total Liabilities

Latest as of December 2025: €1.36 Billion EUR ≈ $1.59 Billion USD

Based on the latest financial reports, Argen-X (ARGX) has total liabilities worth €1.36 Billion EUR (≈ $1.59 Billion USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Argen-X equity growth rate to track the company's year-over-year net asset growth rate.

Argen-X - Total Liabilities Trend (2010–2025)

This chart illustrates how Argen-X's total liabilities have evolved over time, based on quarterly financial data. See free cash flow generation of Argen-X to measure how efficiently the company converts operating cash flow to free cash.

Argen-X Competitors by Total Liabilities

The table below lists competitors of Argen-X ranked by their total liabilities.

Company	Country	Total Liabilities
China Molybdenum Co Ltd Class A SHG:603993	China	CN¥90.46 Billion
Cenovus Energy Inc TO:CVE	Canada	CA$32.31 Billion
E.ON SE F:EOAA	Germany	€84.85 Billion
Ferrovial SE NASDAQ:FER	USA	$19.75 Billion
Orange S.A. PA:ORA	France	€82.15 Billion
Targa Resources Inc NYSE:TRGP	USA	$21.34 Billion
Adani Ports and Special Economic Zone Limited NSE:ADANIPORTS	India	Rs863.33 Billion
Roche Holding AG SW:RO	Switzerland	CHF62.82 Billion

Liability Composition Analysis (2010–2025)

This chart breaks down Argen-X's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Argen-X stock valuation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	5.23	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.19	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.16	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Argen-X's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Argen-X (2010–2025)

The table below shows the annual total liabilities of Argen-X from 2010 to 2025.

Year	Total Liabilities	Change
2025-12-31	€1.36 Billion ≈ $1.59 Billion	+93.08%
2024-12-31	€704.24 Million ≈ $823.33 Million	+58.27%
2023-12-31	€444.95 Million ≈ $520.19 Million	+38.80%
2022-12-31	€320.56 Million ≈ $374.77 Million	+1.43%
2021-12-31	€316.05 Million ≈ $369.50 Million	-47.79%
2020-12-31	€605.36 Million ≈ $707.72 Million	+40.84%
2019-12-31	€429.81 Million ≈ $502.49 Million	+837.86%
2018-12-31	€45.83 Million ≈ $53.58 Million	+47.05%
2017-12-31	€31.16 Million ≈ $36.43 Million	-30.11%
2016-12-31	€44.59 Million ≈ $52.13 Million	+369.65%
2015-12-31	€9.49 Million ≈ $11.10 Million	-7.36%
2014-12-31	€10.25 Million ≈ $11.98 Million	+124.36%
2013-12-31	€4.57 Million ≈ $5.34 Million	-27.24%
2012-12-31	€6.28 Million ≈ $7.34 Million	+55.30%
2011-12-31	€4.04 Million ≈ $4.73 Million	+99.25%
2010-12-31	€2.03 Million ≈ $2.37 Million	--

About Argen-X

BR:ARGX Belgium Biotechnology

Market Cap

$60.40 Billion

€51.67 Billion EUR

Market Cap Rank

#570 Global

#3 in Belgium

Share Price

€830.80

Change (1 day)

+0.68%

52-Week Range

€464.10 - €830.80

All Time High

€830.80